Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 17, 2022

BUY
$134.21 - $153.93 $1,476 - $1,693
11 Added 0.12%
9,189 $1.23 Million
Q2 2022

Jul 14, 2022

BUY
$137.62 - $174.96 $255,147 - $324,375
1,854 Added 25.31%
9,178 $1.41 Million
Q1 2022

Apr 28, 2022

BUY
$131.98 - $163.75 $75,888 - $94,156
575 Added 8.52%
7,324 $1.19 Million
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $3,437 - $4,349
32 Added 0.48%
6,749 $914,000
Q3 2021

Oct 21, 2021

BUY
$106.4 - $120.78 $46,284 - $52,539
435 Added 6.92%
6,717 $725,000
Q2 2021

Aug 03, 2021

BUY
$105.21 - $117.21 $6,733 - $7,501
64 Added 1.03%
6,282 $707,000
Q1 2021

Apr 12, 2021

SELL
$102.3 - $112.62 $33,656 - $37,051
-329 Reduced 5.03%
6,218 $673,000
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $31,632 - $42,707
393 Added 6.39%
6,547 $701,000
Q3 2020

Oct 08, 2020

BUY
$85.91 - $100.83 $41,838 - $49,104
487 Added 8.59%
6,154 $539,000
Q2 2020

Jul 21, 2020

BUY
$73.37 - $98.18 $63,758 - $85,318
869 Added 18.11%
5,667 $556,000
Q1 2020

Apr 22, 2020

SELL
$64.5 - $97.79 $1,741 - $2,640
-27 Reduced 0.56%
4,798 $365,000
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $118,581 - $148,371
1,644 Added 51.68%
4,825 $428,000
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $77,213 - $92,832
-1,226 Reduced 27.82%
3,181 $241,000
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $854 - $1,091
-13 Reduced 0.29%
4,407 $321,000
Q1 2019

May 06, 2019

SELL
$77.14 - $90.79 $8,022 - $9,442
-104 Reduced 2.3%
4,420 $356,000
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $26,780 - $33,027
344 Added 8.23%
4,524 $417,000
Q3 2018

Oct 17, 2018

SELL
$88.91 - $98.84 $23,027 - $25,599
-259 Reduced 5.83%
4,180 $395,000
Q2 2018

Aug 07, 2018

BUY
$89.78 - $106.23 $398,533 - $471,554
4,439 New
4,439 $411,000
Q1 2018

May 01, 2018

SELL
$92.01 - $123.21 $260,940 - $349,423
-2,836 Closed
0 $0
Q4 2017

Jan 26, 2018

BUY
$89.56 - $98.21 $2,865 - $3,142
32 Added 1.14%
2,836 $274,000
Q3 2017

Nov 09, 2017

SELL
$69.85 - $89.22 $31,781 - $40,595
-455 Reduced 13.96%
2,804 $249,000
Q2 2017

Aug 15, 2017

BUY
N/A
3,259
3,259 $236,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Highland Private Wealth Management Portfolio

Follow Highland Private Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Private Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Highland Private Wealth Management with notifications on news.